Global and United States Diabetic Gastroparesis Treatment Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Diabetic gastroparesis refers to cases of the digestive condition gastroparesis that diabetes causes.

During normal digestion, the stomach contracts to help break down food and move it into the small intestine. Gastroparesis disrupts the stomach’s contraction, which can interrupt digestion. Diabetes can cause gastroparesis due to its effects on the nervous system.

Both type 1 diabetes and type 2 diabetes can cause nerve damage. One of the nerves diabetes may damage is the vagus nerve. The vagus nerve controls the movement of food through the stomach. When the vagus nerve experiences damage, the muscles in the stomach and other parts of the digestive tract are not able to function properly. When this happens, food cannot move as quickly through the digestive system. Gastroparesis is also known as delayed gastric emptying.

Market Analysis and Insights: Global and United States Diabetic Gastroparesis Treatment Market
This report focuses on global and United States Diabetic Gastroparesis Treatment market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Diabetic Gastroparesis Treatment market size is estimated to be worth US$ 3615.8 million in 2022 and is forecast to a readjusted size of US$ 5100.2 million by 2028 with a CAGR of 5.9% during the review period. Fully considering the economic change by this health crisis, by Type, Drugs accounting for % of the Diabetic Gastroparesis Treatment global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Hospital Pharmacies was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

Market is not concentrated. Sumitomo, Johnson & Johnson, Sanofi are the leaders of the industry, and hold the key technologies and patent, with high-end customers. Top 3 manufacturer accounted for 7.4% market share in 2019.

Global Diabetic Gastroparesis Treatment Scope and Market Size
Diabetic Gastroparesis Treatment market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Diabetic Gastroparesis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Diabetic Gastroparesis Treatment market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Diabetic Gastroparesis Treatment market is segmented into
    Drugs
    Surgical Treatment Products

Segment by Application, the Diabetic Gastroparesis Treatment market is segmented into
    Hospital Pharmacies
    Private Clinics
    Drug Stores
    E-Commerce

Regional and Country-level Analysis
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Competitive Landscape and Diabetic Gastroparesis Treatment Market Share Analysis
Diabetic Gastroparesis Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Diabetic Gastroparesis Treatment business, the date to enter into the Diabetic Gastroparesis Treatment market, Revenue in Diabetic Gastroparesis Treatment Business (2017-2022) & (US$ Million) introduction, recent developments, etc.

The major vendors covered:
    Sumitomo
    Johnson & Johnson
    Sanofi
    Medtronic
    Pfizer
    Teva
    Boston Scientific

 1 Study Coverage
    1.1 Diabetic Gastroparesis Treatment Revenue in Diabetic Gastroparesis Treatment Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Diabetic Gastroparesis Treatment Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Diabetic Gastroparesis Treatment Market Size for the Year 2017-2028
        1.2.2 Global Diabetic Gastroparesis Treatment Market Size for the Year 2017-2028
    1.3 Diabetic Gastroparesis Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Diabetic Gastroparesis Treatment in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Diabetic Gastroparesis Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Diabetic Gastroparesis Treatment Market Dynamics
        1.4.1 Diabetic Gastroparesis Treatment Industry Trends
        1.4.2 Diabetic Gastroparesis Treatment Market Drivers
        1.4.3 Diabetic Gastroparesis Treatment Market Challenges
        1.4.4 Diabetic Gastroparesis Treatment Market Restraints
    1.5 Study Objectives
    1.6 Years Considered

 2 Diabetic Gastroparesis Treatment by Type
    2.1 Diabetic Gastroparesis Treatment Market Segment by Type
        2.1.1 Drugs
        2.1.2 Surgical Treatment Products
    2.2 Global Diabetic Gastroparesis Treatment Market Size by Type (2017, 2022 & 2028)
    2.3 Global Diabetic Gastroparesis Treatment Market Size by Type (2017-2028)
    2.4 United States Diabetic Gastroparesis Treatment Market Size by Type (2017, 2022 & 2028)
    2.5 United States Diabetic Gastroparesis Treatment Market Size by Type (2017-2028)

 3 Diabetic Gastroparesis Treatment by Application
    3.1 Diabetic Gastroparesis Treatment Market Segment by Application
        3.1.1 Hospital Pharmacies
        3.1.2 Private Clinics
        3.1.3 Drug Stores
        3.1.4 E-Commerce
    3.2 Global Diabetic Gastroparesis Treatment Market Size by Application (2017, 2022 & 2028)
    3.3 Global Diabetic Gastroparesis Treatment Market Size by Application (2017-2028)
    3.4 United States Diabetic Gastroparesis Treatment Market Size by Application (2017, 2022 & 2028)
    3.5 United States Diabetic Gastroparesis Treatment Market Size by Application (2017-2028)

 4 Global Diabetic Gastroparesis Treatment Competitor Landscape by Company
    4.1 Global Diabetic Gastroparesis Treatment Market Size by Company
        4.1.1 Top Global Diabetic Gastroparesis Treatment Companies Ranked by Revenue (2021)
        4.1.2 Global Diabetic Gastroparesis Treatment Revenue by Player (2017-2022)
    4.2 Global Diabetic Gastroparesis Treatment Concentration Ratio (CR)
        4.2.1 Diabetic Gastroparesis Treatment Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Diabetic Gastroparesis Treatment in 2021
        4.2.3 Global Diabetic Gastroparesis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Diabetic Gastroparesis Treatment Headquarters, Revenue in Diabetic Gastroparesis Treatment Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Diabetic Gastroparesis Treatment Headquarters and Area Served
        4.3.2 Global Diabetic Gastroparesis Treatment Companies Revenue in Diabetic Gastroparesis Treatment Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Diabetic Gastroparesis Treatment Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Diabetic Gastroparesis Treatment Market Size by Company
        4.5.1 Top Diabetic Gastroparesis Treatment Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Diabetic Gastroparesis Treatment Revenue by Players (2020, 2021 & 2022)

 5 Global Diabetic Gastroparesis Treatment Market Size by Region
    5.1 Global Diabetic Gastroparesis Treatment Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Diabetic Gastroparesis Treatment Market Size by Region (2017-2028)
        5.2.1 Global Diabetic Gastroparesis Treatment Market Size by Region: 2017-2022
        5.2.2 Global Diabetic Gastroparesis Treatment Market Size by Region (2023-2028)

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Diabetic Gastroparesis Treatment Market Size YoY Growth 2017-2028
        6.1.2 North America Diabetic Gastroparesis Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Diabetic Gastroparesis Treatment Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Diabetic Gastroparesis Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Diabetic Gastroparesis Treatment Market Size YoY Growth 2017-2028
        6.3.2 Europe Diabetic Gastroparesis Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Diabetic Gastroparesis Treatment Market Size YoY Growth 2017-2028
        6.4.2 Latin America Diabetic Gastroparesis Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Diabetic Gastroparesis Treatment Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Diabetic Gastroparesis Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 Sumitomo
        7.1.1 Sumitomo Company Details
        7.1.2 Sumitomo Business Overview
        7.1.3 Sumitomo Diabetic Gastroparesis Treatment Introduction
        7.1.4 Sumitomo Revenue in Diabetic Gastroparesis Treatment Business (2017-2022)
        7.1.5 Sumitomo Recent Development
    7.2 Johnson & Johnson
        7.2.1 Johnson & Johnson Company Details
        7.2.2 Johnson & Johnson Business Overview
        7.2.3 Johnson & Johnson Diabetic Gastroparesis Treatment Introduction
        7.2.4 Johnson & Johnson Revenue in Diabetic Gastroparesis Treatment Business (2017-2022)
        7.2.5 Johnson & Johnson Recent Development
    7.3 Sanofi
        7.3.1 Sanofi Company Details
        7.3.2 Sanofi Business Overview
        7.3.3 Sanofi Diabetic Gastroparesis Treatment Introduction
        7.3.4 Sanofi Revenue in Diabetic Gastroparesis Treatment Business (2017-2022)
        7.3.5 Sanofi Recent Development
    7.4 Medtronic
        7.4.1 Medtronic Company Details
        7.4.2 Medtronic Business Overview
        7.4.3 Medtronic Diabetic Gastroparesis Treatment Introduction
        7.4.4 Medtronic Revenue in Diabetic Gastroparesis Treatment Business (2017-2022)
        7.4.5 Medtronic Recent Development
    7.5 Pfizer
        7.5.1 Pfizer Company Details
        7.5.2 Pfizer Business Overview
        7.5.3 Pfizer Diabetic Gastroparesis Treatment Introduction
        7.5.4 Pfizer Revenue in Diabetic Gastroparesis Treatment Business (2017-2022)
        7.5.5 Pfizer Recent Development
    7.6 Teva
        7.6.1 Teva Company Details
        7.6.2 Teva Business Overview
        7.6.3 Teva Diabetic Gastroparesis Treatment Introduction
        7.6.4 Teva Revenue in Diabetic Gastroparesis Treatment Business (2017-2022)
        7.6.5 Teva Recent Development
    7.7 Boston Scientific
        7.7.1 Boston Scientific Company Details
        7.7.2 Boston Scientific Business Overview
        7.7.3 Boston Scientific Diabetic Gastroparesis Treatment Introduction
        7.7.4 Boston Scientific Revenue in Diabetic Gastroparesis Treatment Business (2017-2022)
        7.7.5 Boston Scientific Recent Development

 8 Research Findings and Conclusion

 9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Diabetic Gastroparesis Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Diabetic Gastroparesis Treatment Market Trends
    Table 3. Diabetic Gastroparesis Treatment Market Drivers
    Table 4. Diabetic Gastroparesis Treatment Market Challenges
    Table 5. Diabetic Gastroparesis Treatment Market Restraints
    Table 6. Global Diabetic Gastroparesis Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Diabetic Gastroparesis Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Diabetic Gastroparesis Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Diabetic Gastroparesis Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Diabetic Gastroparesis Treatment Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Diabetic Gastroparesis Treatment Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Diabetic Gastroparesis Treatment Revenue Share by Player, 2017-2022
    Table 13. Global Diabetic Gastroparesis Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Diabetic Gastroparesis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Gastroparesis Treatment as of 2021)
    Table 15. Top Players of Diabetic Gastroparesis Treatment in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Diabetic Gastroparesis Treatment Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Diabetic Gastroparesis Treatment Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Diabetic Gastroparesis Treatment Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Diabetic Gastroparesis Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Diabetic Gastroparesis Treatment Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Diabetic Gastroparesis Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Diabetic Gastroparesis Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Diabetic Gastroparesis Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Diabetic Gastroparesis Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Diabetic Gastroparesis Treatment Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Diabetic Gastroparesis Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Diabetic Gastroparesis Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Diabetic Gastroparesis Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Sumitomo Company Details
    Table 31. Sumitomo Business Overview
    Table 32. Sumitomo Diabetic Gastroparesis Treatment Product
    Table 33. Sumitomo Revenue in Diabetic Gastroparesis Treatment Business (2017-2022) & (US$ Million)
    Table 34. Sumitomo Recent Development
    Table 35. Johnson & Johnson Company Details
    Table 36. Johnson & Johnson Business Overview
    Table 37. Johnson & Johnson Diabetic Gastroparesis Treatment Product
    Table 38. Johnson & Johnson Revenue in Diabetic Gastroparesis Treatment Business (2017-2022) & (US$ Million)
    Table 39. Johnson & Johnson Recent Development
    Table 40. Sanofi Company Details
    Table 41. Sanofi Business Overview
    Table 42. Sanofi Diabetic Gastroparesis Treatment Product
    Table 43. Sanofi Revenue in Diabetic Gastroparesis Treatment Business (2017-2022) & (US$ Million)
    Table 44. Sanofi Recent Development
    Table 45. Medtronic Company Details
    Table 46. Medtronic Business Overview
    Table 47. Medtronic Diabetic Gastroparesis Treatment Product
    Table 48. Medtronic Revenue in Diabetic Gastroparesis Treatment Business (2017-2022) & (US$ Million)
    Table 49. Medtronic Recent Development
    Table 50. Pfizer Company Details
    Table 51. Pfizer Business Overview
    Table 52. Pfizer Diabetic Gastroparesis Treatment Product
    Table 53. Pfizer Revenue in Diabetic Gastroparesis Treatment Business (2017-2022) & (US$ Million)
    Table 54. Pfizer Recent Development
    Table 55. Teva Company Details
    Table 56. Teva Business Overview
    Table 57. Teva Diabetic Gastroparesis Treatment Product
    Table 58. Teva Revenue in Diabetic Gastroparesis Treatment Business (2017-2022) & (US$ Million)
    Table 59. Teva Recent Development
    Table 60. Boston Scientific Company Details
    Table 61. Boston Scientific Business Overview
    Table 62. Boston Scientific Diabetic Gastroparesis Treatment Product
    Table 63. Boston Scientific Revenue in Diabetic Gastroparesis Treatment Business (2017-2022) & (US$ Million)
    Table 64. Boston Scientific Recent Development
    Table 65. Research Programs/Design for This Report
    Table 66. Key Data Information from Secondary Sources
    Table 67. Key Data Information from Primary Sources
List of Figures
    Figure 1. Diabetic Gastroparesis Treatment Product Picture
    Figure 2. Global Diabetic Gastroparesis Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Diabetic Gastroparesis Treatment Market Size 2017-2028 (US$ Million)
    Figure 4. United States Diabetic Gastroparesis Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Diabetic Gastroparesis Treatment Market Size 2017-2028 (US$ Million)
    Figure 6. United States Diabetic Gastroparesis Treatment Market Share in Global 2017-2028
    Figure 7. Diabetic Gastroparesis Treatment Report Years Considered
    Figure 8. Product Picture of Drugs
    Figure 9. Product Picture of Surgical Treatment Products
    Figure 10. Global Diabetic Gastroparesis Treatment Market Share by Type in 2022 & 2028
    Figure 11. Global Diabetic Gastroparesis Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Diabetic Gastroparesis Treatment Market Share by Type (2017-2028)
    Figure 13. United States Diabetic Gastroparesis Treatment Market Share by Type in 2022 & 2028
    Figure 14. United States Diabetic Gastroparesis Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Diabetic Gastroparesis Treatment Market Share by Type (2017-2028)
    Figure 16. Product Picture of Hospital Pharmacies
    Figure 17. Product Picture of Private Clinics
    Figure 18. Product Picture of Drug Stores
    Figure 19. Product Picture of E-Commerce
    Figure 20. Global Diabetic Gastroparesis Treatment Market Share by Application in 2022 & 2028
    Figure 21. Global Diabetic Gastroparesis Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 22. Global Diabetic Gastroparesis Treatment Market Share by Application (2017-2028)
    Figure 23. United States Diabetic Gastroparesis Treatment Market Share by Application in 2022 & 2028
    Figure 24. United States Diabetic Gastroparesis Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. United States Diabetic Gastroparesis Treatment Market Share by Application (2017-2028)
    Figure 26. North America Diabetic Gastroparesis Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 27. U.S. Diabetic Gastroparesis Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Canada Diabetic Gastroparesis Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Europe Diabetic Gastroparesis Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. Germany Diabetic Gastroparesis Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. France Diabetic Gastroparesis Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. U.K. Diabetic Gastroparesis Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Italy Diabetic Gastroparesis Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Russia Diabetic Gastroparesis Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Diabetic Gastroparesis Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 36. China Diabetic Gastroparesis Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Japan Diabetic Gastroparesis Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. South Korea Diabetic Gastroparesis Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. India Diabetic Gastroparesis Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Australia Diabetic Gastroparesis Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. China Taiwan Diabetic Gastroparesis Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Indonesia Diabetic Gastroparesis Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Thailand Diabetic Gastroparesis Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Malaysia Diabetic Gastroparesis Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Latin America Diabetic Gastroparesis Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 46. Mexico Diabetic Gastroparesis Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Brazil Diabetic Gastroparesis Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Argentina Diabetic Gastroparesis Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Diabetic Gastroparesis Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Turkey Diabetic Gastroparesis Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Diabetic Gastroparesis Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. UAE Diabetic Gastroparesis Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Sumitomo Revenue Growth Rate in Diabetic Gastroparesis Treatment Business (2017-2022)
    Figure 54. Johnson & Johnson Revenue Growth Rate in Diabetic Gastroparesis Treatment Business (2017-2022)
    Figure 55. Sanofi Revenue Growth Rate in Diabetic Gastroparesis Treatment Business (2017-2022)
    Figure 56. Medtronic Revenue Growth Rate in Diabetic Gastroparesis Treatment Business (2017-2022)
    Figure 57. Pfizer Revenue Growth Rate in Diabetic Gastroparesis Treatment Business (2017-2022)
    Figure 58. Teva Revenue Growth Rate in Diabetic Gastroparesis Treatment Business (2017-2022)
    Figure 59. Boston Scientific Revenue Growth Rate in Diabetic Gastroparesis Treatment Business (2017-2022)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed

Diabetic gastroparesis refers to cases of the digestive condition gastroparesis that diabetes causes.

During normal digestion, the stomach contracts to help break down food and move it into the small intestine. Gastroparesis disrupts the stomach’s contraction, which can interrupt digestion. Diabetes can cause gastroparesis due to its effects on the nervous system.

Both type 1 diabetes and type 2 diabetes can cause nerve damage. One of the nerves diabetes may damage is the vagus nerve. The vagus nerve controls the movement of food through the stomach. When the vagus nerve experiences damage, the muscles in the stomach and other parts of the digestive tract are not able to function properly. When this happens, food cannot move as quickly through the digestive system. Gastroparesis is also known as delayed gastric emptying.

Market Analysis and Insights: Global and United States Diabetic Gastroparesis Treatment Market
This report focuses on global and United States Diabetic Gastroparesis Treatment market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Diabetic Gastroparesis Treatment market size is estimated to be worth US$ 3615.8 million in 2022 and is forecast to a readjusted size of US$ 5100.2 million by 2028 with a CAGR of 5.9% during the review period. Fully considering the economic change by this health crisis, by Type, Drugs accounting for % of the Diabetic Gastroparesis Treatment global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Hospital Pharmacies was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

Market is not concentrated. Sumitomo, Johnson & Johnson, Sanofi are the leaders of the industry, and hold the key technologies and patent, with high-end customers. Top 3 manufacturer accounted for 7.4% market share in 2019.

Global Diabetic Gastroparesis Treatment Scope and Market Size
Diabetic Gastroparesis Treatment market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Diabetic Gastroparesis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Diabetic Gastroparesis Treatment market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Diabetic Gastroparesis Treatment market is segmented into
    Drugs
    Surgical Treatment Products

Segment by Application, the Diabetic Gastroparesis Treatment market is segmented into
    Hospital Pharmacies
    Private Clinics
    Drug Stores
    E-Commerce

Regional and Country-level Analysis
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Competitive Landscape and Diabetic Gastroparesis Treatment Market Share Analysis
Diabetic Gastroparesis Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Diabetic Gastroparesis Treatment business, the date to enter into the Diabetic Gastroparesis Treatment market, Revenue in Diabetic Gastroparesis Treatment Business (2017-2022) & (US$ Million) introduction, recent developments, etc.

The major vendors covered:
    Sumitomo
    Johnson & Johnson
    Sanofi
    Medtronic
    Pfizer
    Teva
    Boston Scientific